Abstract:New Zn(II) Mn(III) complexes were prepared using Schiff base (HL) ligands by condensation of 2‐hydroxy‐1‐naphthaldehyde with 2‐methoxyethylamine. All the synthesized compounds were identified using spectroscopic technique. The crystal structure of the new compounds was obtained by X‐ray diffraction. Molecular docking studies were performed to predict the possible binding modes between the tested compounds and the active sites of the receptors. Hirshfeld surface analysis (HSA), DFT theoretical calculations, and molecular electrostatic potential (MEP) were performed to elucidate the interesting structural features of the complexes. A new series of transition metal complexes of bidentate Schiff base compound derived from 2‐hydroxy‐1‐(2‐methoxyethylimino)‐naphthalene (HL) were synthesized and characterized using elemental analysis, Fourier transform infrared spectroscopy (FT‐IR), and UV–vis spectroscopies. X‐ray single crystal structures of Zn(II), Mn(III), and Co(III) complexes (1–4) have also been determined, and it was indicated that these Zn(II) and Co(III) complexes (1, 4) are in an octahedral geometry. Whereas, it was found that the Zn complex (2) is in quite a regular tetrahedral environment. Also, the Mn center in complex (3) is ligated by two azomethine nitrogen atoms, two ligand oxygen atoms, and one Cl atom of metal salt forming five coordinated tetragonal pyramid geometry around the Mn atoms. The cyclic voltammetry of the complexes specifies an irreversible redox behavior for all complexes (1–4). Next, DFT/B3LYP theoretical method was used to determine the optimal geometrical configurations and comparison between experimental and theoretical data, as well as for calculations of molecular electrostatic potential, highest‐occupied molecular orbital (HOMO)‐lowest‐unoccupied molecular orbital (LUMO) energy values of selected compounds. The study of non‐covalent interactions was done by Hirshfeld surface analysis using CrystalExplorer program. Furthermore, molecular docking inspection was carried out to study the binding affinity of the tested complexes towards protein B‐cell lymphorna (PDB ID: 4LXD). Using the results obtained from the molecular docking and the summarized interaction of the binding processes, these structures show the validity of effective inhibition against liver cancer.

Transition metal manganese(II), nickel(II), copper(II) and zinc(II) complexes of a new Schiff base ligand: Synthesis, characterization and antitumor activity studies

Synthesis and Crystal Structure of Some Transition Metal Complexes with A Novel Bis-Schiff Base Ligand and Their Antitumor Activities

The Crystal Structures of Copper(ii), Manganese(ii), and Nickel(ii) Complexes of a (Z)-2-hydroxy-n′-(2-oxoindolin-3-ylidene) Benzohydrazide—potential Antitumor Agents

Synthesis, structure and anticancer studies of Cu (II), Ni (II) and Co (II) complexes based on 2,3-dihydroxybenzaldehyde-2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, crystal structures and anticancer studies of Ni (II), Co (III) and Zn (II) complexes based on 5-bromosalicylaldehyde- 2-(2-aminophenyl)benzimidazole Schiff base

Synthesis, Characterization, Antioxidant and Antimicrobial Activities of A Bidentate Schiff Base Ligand and Its Metal Complexes

Zn(II), Mn(III), and Co(III) complexes of Schiff base derived from 2‐hydroxy‐1‐naphthaldehyde: Synthesis, spectral surveys, single crystal structure studies, Hirshfeld surface analysis, density functional theory calculation, molecular electrostatic potential, and molecular docking evaluations

Synthesis, Structural Characterization and Preliminary Biological Studies of Several Heterocyclic Transition Metal Carbonyl Complexes

New Ligand-Based Metal Complexes: Synthesis, Spectroscopic Characterization, Thermal Behavior, Anticancer Properties, and Biological Activity

Exploration on Synthesis, Characterization and Biological Activities of Transition Metal Complexes Comprising Hydroxybenzylideneaminocyclohexylimino-methyl-4,6-dibromophenol Schiff Base Ligand

Synthesis, characterization, crystal structure, and biological activities of transition metal complexes with 1-phenyl-3-methyl-5-hydroxypyrazole-4- methylene-8′-quinolineimine

Synthesis and Characterization of Metal Complexes with Unsymmetrical Tetradentate Schiff Base Ligand

Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates

Physico-Chemical Study of Mn(II), Co(II), Cu(II), Cr(III), and Pd(II) Complexes with Schiff-Base and Aminopyrimidyl Derivatives and Anti-Cancer, Antioxidant, Antimicrobial Applications

New cytotoxic zinc(II) and copper(II) complexes of Schiff base ligands derived from homopiperonylamine and halogenated salicylaldehyde

Synthesis, properties, structure and bioactivity in vitro of mononuclear complexes of manganese and nickel with hydroxyethyltribenzimidazolylmethyl ethylene diamine

Syntheses, Structures, DNA/BSA Binding and Cytotoxic Activity Studies of Chiral Alcohol-Amine Schiff Base Manganese (II/III) Complexes

Synthesis and Characterization of Unsymmetrical Schiff Base Complexes

Synthesis, Characterization and Anticancer Activities of Transition Metal Complexes with a Nicotinohydrazone Ligand.

The X-ray crystal structures, molecular docking and biological activities of two novel Cu(II) and Zn(II) complexes with a ligand having a potentially N4O2 donor set and two nitro phenyl rings as pendant arms

Synthesis, Characterization and in Vitro Biological Activity of Cobalt(ii), Copper(ii) and Zinc(ii) Schiff Base Complexes Derived from Salicylaldehyde and D,L‐selenomethionine